Nakamoto Inc.
Financial ServicesNASDAQ:NAKA · NASDAQ Global Market
-$0.15 today
Vol 0.25M · Avg 0.22M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$3.9M of revenue converted into -$290.0M of net income for the selected period. Gross margin is -593.4% and net margin is -5823.8%, showing how much revenue survives after costs and taxes. EPS is $-29.55, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8M -33.0% | $2.7M -27.8% | $3.8M -0.5% | $3.8M +51.2% | $2.5M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $11.1M +211.3% | $3.6M +1475.1% | $226.2K +48.4% | $152.4K -90.4% | $1.6M | $725.6M | $804.0M | $882.4M |
| Gross Profit | -$9.3M -999.8% | -$842.6K -123.8% | $3.5M -2.5% | $3.6M +297.3% | $914.9K | $8.9B | $7.6B | $6.2B |
| Gross Margin | -508.8% -477.8pp | -31.0% -125.0pp | 94.0% -2.0pp | 96.0% +59.4pp | 36.5% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 -100.0% | $377.7K +15009.2% | $2.5K | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $11.8M +516.8% | $1.9M -62.3% | $5.1M -19.4% | $6.3M +635.1% | $853.6K | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $187.9M +7402.3% | $2.5M -51.5% | $5.2M -18.4% | $6.3M +641.4% | $853.6K | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $242.0K +9.8% | $220.3K +8.4% | $203.2K +66.6% | $122.0K +92.4% | $63.4K | $374.2M | $1.2B | $631.8M |
| EBITDA | -$44.9M -1395.6% | -$3.0M -121.1% | -$1.4M +43.8% | -$2.4M -2038.9% | $124.7K | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -2466.7% -2356.3pp | -110.4% -74.4pp | -36.0% +27.8pp | -63.9% -68.8pp | 5.0% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$197.1M -5790.4% | -$3.3M -106.6% | -$1.6M +39.8% | -$2.7M -4491.0% | $61.3K | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -10824.0% -10701.0pp | -123.1% -80.1pp | -43.0% +28.1pp | -71.1% -73.6pp | 2.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $7.1M +1694.5% | $393.4K +604.5% | $55.8K | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $144.9M +53596.9% | -$270.9K -9917.9% | $2.8K -98.2% | $152.8K +73.7% | $88.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$52.2M -1343.7% | -$3.6M -123.7% | -$1.6M +36.3% | -$2.5M -1801.3% | $149.3K | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -2867.6% -2734.6pp | -133.0% -90.1pp | -42.9% +24.2pp | -67.1% -73.0pp | 6.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.6B | $745.2M |
| Net Income | -$52.2M -1343.7% | -$3.6M -123.7% | -$1.6M +36.3% | -$2.5M -1801.3% | $149.3K | $4.9B | $4.8B | $4.7B |
| Net Margin | -2867.6% -2734.6pp | -133.0% -90.1pp | -42.9% +24.2pp | -67.1% -73.0pp | 6.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$10 -1452.2% | -$1 -148.1% | -$0 +37.2% | -$0 -1820.0% | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$10 -1452.2% | -$1 -148.1% | -$0 +37.2% | -$0 -1820.0% | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $11.4M +110.8% | $5.4M -8.5% | $5.9M +0.0% | $5.9M -1.4% | $6.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $11.4M +110.8% | $5.4M -8.5% | $5.9M +0.0% | $5.9M -1.4% | $6.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.88B
DBV Technologies S.A.
NASDAQ:DBVT
$416.60M
Delcath Systems, Inc.
NASDAQ:DCTH
$404.59M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$349.74M
Simulations Plus, Inc.
NASDAQ:SLP
$329.75M
Amarin Corporation plc
NASDAQ:AMRN
$315.21M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$315.01M
Cellectis S.A.
NASDAQ:CLLS
$310.29M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$296.96M
Definitive Healthcare Corp.
NASDAQ:DH
$88.59M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does NAKA generate?
Nakamoto Inc. (NAKA) reported $1.82M of revenue in fiscal 2025.
Is NAKA profitable?
Nakamoto Inc. (NAKA) reported -$52,228,923.00 of net income, with a net margin of -2867.6%.
Explore More
Continue the stock analysis
Jump to another research area for this company.